Walter & Keenan Wealth Management LLC Abb Vie Inc. Transaction History

Walter & Keenan Wealth Management LLC

$304 Million
Q1 2024

A detailed history of Walter & Keenan Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Walter & Keenan Wealth Management LLC holds 27,282 shares of ABBV stock, worth $4.56 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

27,282

Previous 28,681 4.88%

Holding current value

$4.56 Million

Previous $4.44 Million 11.79%

% of portfolio

1.63%

Previous 1.6%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $223,588 - $254,757	-1,399 Reduced 4.88%	27,282 $4.97 Million
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $9,632 - $10,847	70 Added 0.24%	28,681 $4.44 Million
Q3 2023 Oct 20, 2023	SELL	$133.59 - $154.65 $72,272 - $83,665	-541 Reduced 1.86%	28,611 $4.26 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $77,120 - $95,971	-582 Reduced 1.96%	29,152 $3.93 Million
Q1 2023 Apr 26, 2023	SELL	$144.61 - $166.54 $187,269 - $215,669	-1,295 Reduced 4.17%	29,734 $4.74 Million

Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $111,616 - $133,857	807 Added 2.67%	31,029 $5.02 Million
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $79,049 - $90,664	589 Added 1.99%	30,222 $4.06 Million
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $60,415 - $76,807	-439 Reduced 1.46%	29,633 $4.54 Million
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $10,635 - $13,457	-99 Reduced 0.33%	30,072 $4.07 Million
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $12,555 - $14,252	-118 Reduced 0.39%	30,171 $3.26 Million
Q2 2021 Jul 13, 2021	SELL	$105.21 - $117.21 $25,250 - $28,130	-240 Reduced 0.79%	30,289 $3.41 Million
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $34,782 - $38,290	-340 Reduced 1.1%	30,529 $3.3 Million
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $31,632 - $42,707	-393 Reduced 1.26%	30,869 $3.31 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $104,466 - $122,609	1,216 Added 4.05%	31,262 $2.74 Million
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $1.84 Million - $2.46 Million	25,016 Added 497.34%	30,046 $2.95 Million
Q1 2020 Apr 14, 2020	SELL	$64.5 - $97.79 $1.52 Million - $2.3 Million	-23,537 Reduced 82.39%	5,030 $369,000
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $7,285 - $9,115	101 Added 0.35%	28,567 $2.53 Million
Q3 2019 Oct 28, 2019	BUY	$62.98 - $75.72 $106,814 - $128,421	1,696 Added 6.34%	28,466 $2.16 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $34,635 - $40,764	449 Added 1.71%	26,770 $2.16 Million
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $49,345 - $54,856	555 Added 2.15%	26,321 $2.49 Million
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $606,015 - $717,052	-6,750 Reduced 20.76%	25,766 $2.39 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $230,025 - $308,025	-2,500 Reduced 7.14%	32,516 $3.08 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $2.45 Million - $3.12 Million	35,016	35,016 $3.11 Million

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walter & Keenan Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Walter & Keenan Wealth Management LLC with notifications on news.

Account

Walter & Keenan Wealth Management LLC Abb Vie Inc. Transaction History